‘Super-powers of hemp’: Cannabis pharmacy opens in London

Image from facebook.com/CarunUK
Britain’s first-ever cannabis pharmacy, selling health and beauty products made of hemp, is set to open its doors this week.

The pharmacy Carun UK, based in Twickenham, southwest London, uses the “healing super-powers of hemp” which is the “ultimate skin savior and well-being booster.”

However, the company said the products, including oils and hand creams, cannot get their customers high.

READ MORE: Daze in the park: 420 cannabis festival returns to UK

READ MORE: High hopes: Cannabis legalization party to stand in UK general election

READ MORE: £5K spent prosecuting man over cannabis worth less than £2

“These support our immune system; restore the balance and health of cells as well as possessing anti-inflammatory, antiseptic and antibiotic properties,” Carun’s UK managing director Michal Takac said.

“But no … they will not and cannot make you high.”

The beauty products are made from active cannabis extracts which can also be used to treat skin conditions like acne, rashes and scars. The hemp is grown in the Czech Republic.

“The products are enriched with cannabis sativa extract which contains anti-inflammatory cannabinoids,” the company’s website explains.

“These compounds are already produced naturally by our bodies, and support our immune system, restore the balance and health of cells, as well as possessing anti-inflammatory, antiseptic, and antibiotic properties.”

Marijuana has a tetrahydrocannabino (THC) level of 20 to 30 percent, which is the chemical that causes the effects of feeling high. In contrast, Carun products only have a level of only 0.3 percent.

Carun, a Czech company, is not the first in the UK to sell hemp products. The Body Shop launched a hemp product range almost 20 years ago.

Another company using hemp is GW Pharmaceuticals. The British company makes medicines from cannabis, which it grows in England, with permission from the government. It recently raised $180m in New York to fund the development of a treatment for childhood epilepsy.